NAMENDA XR (memantine hydrochloride) extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. NAMENDA XR is an NMDA receptor antagonist indicated for the treatment of moderate to severe…
NAMENDA XR is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. NAMENDA XR is a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the…
NAMZARIC is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type in patients stabilized on 10 mg of donepezil hydrochloride once daily. NAMZARIC is a…
Nandrolone decanoate is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. Surgically induced anephric patients have been reported to be less responsive. CONTRAINDICATIONS:…
Carefully consider the potential benefits and risks of NAPRELAN Tablets and other treatment options before deciding to use NAPRELAN Tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2023. All Rights Reserved.